Hansa Biopharma

We are a fast-growing, R&D-driven biopharmaceutical company, with a mission to develop innovative lifesaving and life altering immunomodulating therapies, bring them to the patients with rare diseases who need them, and generate value to society at large. We leverage our immunomodulatory platform to develop treatments which enable transplantations and advance research in disease areas such as rare immunoglobulin G (IgG)-mediated autoimmune conditions, gene therapy and cancer. Our first product in kidney transplantation has been granted conditional authorization in the EU/EAA and UK. It’s an exciting time to be part of the Hansa team, we are just getting started!